Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $12.81 in the prior trading day, Stoke Therapeutics Inc (NASDAQ: STOK) closed at $12.5, down -2.42%. In other words, the price has decreased by -$2.42 from its previous closing price. On the day, 0.82 million shares were traded. STOK stock price reached its highest trading level at $12.88 during the session, while it also had its lowest trading level at $12.25.
Ratios:
Our goal is to gain a better understanding of STOK by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.91 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.86. For the most recent quarter (mrq), Quick Ratio is recorded 8.41 and its Current Ratio is at 8.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on July 18, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $24.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 01 ’25 when Ticho Barry sold 4,503 shares for $11.63 per share. The transaction valued at 52,379 led to the insider holds 21,279 shares of the business.
BARUCH TICHO bought 9,007 shares of STOK for $102,229 on Jul 01 ’25. On Jun 04 ’25, another insider, Skorpios Trust, who serves as the 10% Owner of the company, sold 3,000,000 shares for $10.20 each. As a result, the insider received 30,600,000 and left with 3,906,181 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STOK now has a Market Capitalization of 682461248 and an Enterprise Value of 329349536. As of this moment, Stoke’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.57 while its Price-to-Book (P/B) ratio in mrq is 1.95. Its current Enterprise Value per Revenue stands at 1.725 whereas that against EBITDA is 8.166.
Stock Price History:
The Beta on a monthly basis for STOK is 1.16, which has changed by -0.16499668 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, STOK has reached a high of $16.15, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is 9.48%, while the 200-Day Moving Average is calculated to be 18.47%.
Shares Statistics:
The stock has traded on average 682.27K shares per day over the past 3-months and 1049760 shares per day over the last 10 days, according to various share statistics. A total of 54.60M shares are outstanding, with a floating share count of 45.85M. Insiders hold about 16.02% of the company’s shares, while institutions hold 98.10% stake in the company. Shares short for STOK as of 1752537600 were 11496684 with a Short Ratio of 16.85, compared to 1749772800 on 12107800. Therefore, it implies a Short% of Shares Outstanding of 11496684 and a Short% of Float of 25.480000000000004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
